Semaglutide Research

Semaglutide Shines as Weight Loss Therapy | MedPage Today 

Once-Weekly Semaglutide in Adults with Overweight or Obesity - PubMed (nih.gov) 

Semaglutide 2.4 mg 'Ushers in a New Era in Medical Obesity Care' (medscape.com) 

Semaglutide for Treatment of Obesity (obesitymedicine.org) 

Semaglutide Boosts Weight Loss Following Endoscopic Gastroplasty (medscape.com) 

Updates on Semaglutide for Weight Loss, From ENDO 2021 (medscape.com) 

Semaglutide Treatment Effect in People With Obesity - American College of Cardiology (acc.org) 

The Pros and Cons of Semaglutide for Weight Loss (insider.com) 

Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial | Nature Medicine 

https://www.insider.com/semaglutide-how-does-drug-work-for-weight-loss-diabetes-2021-5

Drug for Type 2 Diabetes Effective in Weight Loss (healthline.com) 

The improved health utility of once-weekly subcutaneous semaglutide 2.4 mg compared with placebo in the STEP 1-4 obesity trials - PubMed (nih.gov) 

Exploring the wider benefits of semaglutide treatment in obesity: insight from the STEP program - PubMed (nih.gov) 

The New Obesity Breakthrough Drugs (medscape.com) 

'Game Changer' Semaglutide Halves Diabetes Risk From Obesity (medscape.com) 

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes | NEJM 

Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes (medscape.com) 

Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson's Disease - PubMed (nih.gov) 

Obesity Treatment in Mental Illness: Is Semaglutide a Game Changer? (medscape.com) 

Proof That Substantial Weight Loss Lessens COVID-19 Severity (medscape.com) 

Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson's Disease - PubMed (nih.gov) 

GLP1R in Parkinson's Disease - Full Text View - ClinicalTrials.gov 

Semaglutide – The Science of Parkinson's (scienceofparkinsons.com) 

Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review - PMC (nih.gov) 

GLP-1 based therapies and disease course of inflammatory bowel disease - PMC (nih.gov) 

Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials - eClinicalMedicine (thelancet.com) 

Novel Insights into the Roles and Mechanisms of GLP-1 Receptor Agonists against Aging-Related Diseases - PMC (nih.gov) 

Popular Obesity Drug Turns Out to Have a Secret Cancer-Killing Effect : ScienceAlert 

Semaglutide Reduces Triglyceride Levels in Diabetic Patients (hcplive.com) 

Semaglutide improves postprandial glucose and lipid metabolism, and delays first‐hour gastric emptying in subjects with obesity - PMC (nih.gov) 

Semaglutide Shows Promise for Fatty Liver Disease - Hep (hepmag.com) 

Did Scientists Accidentally Invent an Anti-addiction Drug? (msn.com)  

Semaglutide and Weight Loss | Gynecology & Menopause Specialists located in Mount Pleasant, SC | Menopause Solutions 

Surviving Menopause with Diabetes | DiabetesMine (healthline.com) 

How to treat weight gain in menopause (contemporaryobgyn.net) 

Weight, Shape, and Body Composition Changes at Menopause - PMC (nih.gov) 

Weight-Loss Drug Semaglutide May Reduce People's Desire for Alcohol (insider.com) 

Longevity diet: How changing what you eat could add decades to your life | New Scientist 

Semaglutide Diet Plan | Here Are the Exact Foods to Eat! (peptides.org) 

Time-Restricted Eating Gains for Weight and Glycemic Control (medscape.com) 

‘I miss eating’: the truth behind the weight loss drug that makes food repulsive | Food | The Guardian 

Before and after semaglutide: 6 people on the 'game-changer' weight loss drug share its biggest pros and cons (yahoo.com) 

Woman With PCOS Takes Semaglutide: Loses 70 Pounds, Periods Return (insider.com) 

Women Tend to Lose More Weight Than Men With Weight-Loss Drugs (medscape.com) 

Are Weight Loss Medications for Health or Thinness? (medscape.com) 

New Antiobesity Drugs Will Benefit Many. Is That Bad? (medscape.com) 

‘I miss eating’: the truth behind the weight loss drug that makes food repulsive | Food | The Guardian 

Weight Loss Drug Semaglutide Causes Muscle Loss, Doctor Warns (insider.com) 

Is It Bad to Lose Weight Too Fast? – Cleveland Clinic 

Safety of Semaglutide - PubMed (nih.gov) 

Weight Loss: Does the Drug Semaglutide Affect How Food Tastes? (healthline.com) 

Semaglutide Tiredness And Fatigue: The Common Yet Surprising Side Effect (dibesity.com) 

The 14 Semaglutide Side Effects You Should Know About - GoodRx 

5 Undesirable Side Effects from Losing Weight Too Quickly (caloriesecrets.net) 

Optimal Time Period for Weight Loss Drugs: Debate Continues (medscape.com) 

What to know about semaglutide, the 'game changer' drug just approved for obesity treatment (yahoo.com) 

SUSTAIN FORTE: 2-mg Semaglutide Bests 1 mg in Type 2 Diabetes (medscape.com) 

Semaglutide Responsible Use | Official Website (novomedlink.com) 

Rapid Rx Quiz: Semaglutide (medscape.com) 

BMI Is a Flawed Measure of Obesity. What Are Alternatives? (medscape.com) 

How to draw up and give yourself a subcutaneous injection - Bing video 

Emotional Eating Isn't All Emotional (medscape.com) 

The 11 Best Meal Planning Apps to Help You Lose Weight (healthline.com) 

The 13 Best Grocery Delivery Services (healthline.com) 

More STEP Data: Semaglutide Cuts Weight, Cravings, Beats Liraglutide (medscape.com) 

18 Popular Weight Loss Medications and Supplements Reviewed (healthline.com) 

Weight Loss Injections in Stomach: Brands, Efficacy, and Costs (healthline.com) 

What Happens When Newer Weight Loss Meds Are Stopped? (medscape.com) 

Why Is Long-term Weight Loss So Difficult? (medscape.com) 

Woman shares what happened after she stopped taking semaglutide - ABC News (go.com) 

How Dare There Be Effective Drugs for Obesity? (medscape.com) 

Trending Clinical Topic: Semaglutide (medscape.com) 

Effect of once-weekly subcutaneous semaglutide 2.4 mg on weight- and health-related quality of life in an East Asian population: Patient-reported outcomes from the STEP 6 trial - PubMed (nih.gov) 

GLP-1 Receptor Agonists (diatribe.org) 

Obesity Drug Shortage Triggers Frustrations, Workarounds (medscape.com) 

New Generation of Weight Loss Medications Offer Promise (medscape.com) 

Rising Interest in Weight Loss Meds Despite Cost (medscape.com) 

Affording the New Obesity Drugs? We Can't Afford Not to (medscape.com) 

Double Standards Continue in Antiobesity Meds Discourse (medscape.com) 

Social Media and Weight Loss Drugs: Are Regulators Watching? (medscape.com) 

Weight loss treatment is on the verge of transformation. It's not there yet. Here's why. (msn.com) 

The TikTok Trend That Triggered a Diabetes Drug Shortage (medscape.com) 

 New Weight Loss Drugs Appeal to Half of US Adults (medscape.com) 

STEP TEENS: Semaglutide 'Gives Hope' to Adolescents With Obesity (medscape.com) 

Will New Guidelines Widen the Gap in Treating Kids' Obesity? (medscape.com) 

Half of Teens Drop Below Obesity Cutoff With Semaglutide (medscape.com) 

Dementia Risk Higher the Younger a Person Develops Type 2 Diabetes (healthline.com) 

 Type 2 Diabetes Drug Semaglutide may Help Adolescents Lose Weight (healthline.com)